The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
TREM2-Transduced Myeloid Precursors Mediate Nervous Tissue Debris Clearance and Facilitate Recovery in an Animal Model of Multiple Sclerosis
Open accessAbstract
BACKGROUND: In multiple sclerosis, inflammation can successfully be prevented, while promoting repair is still a major challenge. Microglial cells, the resident phagocytes of the central nervous system (CNS), are hematopoietic-derived myeloid cells and express the triggering receptor expressed on myeloid cells 2 (TREM2), an innate immune receptor. Myeloid cells are an accessible source for ex vivo gene therapy. We investigated whether myeloid precursor cells genetically modified to express TREM2 affect the disease course of experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis. METHODS AND FINDINGS: EAE was induced in mice by immunization with a myelin autoantigen. Intravenous application of TREM2-transduced bone marrow-derived myeloid precursor cells at the EAE peak led to an amelioration of clinical symptoms, reduction in axonal damage, and prevention of further demyelination. TREM2-transduced myeloid cells applied intravenously migrated into the inflammatory spinal cord lesions of EAE-diseased mice, showed increased lysosomal and phagocytic activity, cleared degenerated myelin, and created an anti-inflammatory cytokine milieu within the CNS. CONCLUSIONS: Intravenously applied bone marrow-derived and TREM2-tranduced myeloid precursor cells limit tissue destruction and facilitate repair within the murine CNS by clearance of cellular debris during EAE. TREM2 is a new attractive target for promotion of repair and resolution of inflammation in multiple sclerosis and other neuroinflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In particular, the clearance of myelin debris by microglia is believed to be critically required to limit neuronal damage in EAE (Cignarella et al., 2020; Takahashi et al., 2007; Weinger et al., 2011).”
From SYK coordinates neuroprotective microglial responses in neurodegenerative disease (2022) · cites this paper as Takahashi et al., 2007
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“TREM2 promotes proliferation (119), survival (119), and phagocytosis of apoptotic cells (120–122).”
From Microglia Function in the Central Nervous System During Health and Neurodegeneration (2017) · cites this paper as [121]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Resolution of inflammation: the beginning programs the end
Serhan, C. N., & Savill, J. (2005) · Nature Immunology · doi:10.1038/ni1276 · Cited by 2,552 · cited 1×
“Efficient removal of apoptotic cells and cellular debris by macrophages during acute injury or degenerative diseases is essential for repair of the damaged tissue, inflammation resolution, and disease recovery [11–13].”
BackgroundImmunosuppressive effects of apoptotic cells
Voll, R. E., Herrmann, M., Roth, E. A., Stach, C., Kalden, J. R., & Girkontaite, I. (1997) · Nature · doi:10.1038/37022 · Cited by 1,787 · cited 1×
“Efficient removal of apoptotic cells and cellular debris by macrophages during acute injury or degenerative diseases is essential for repair of the damaged tissue, inflammation resolution, and disease recovery [11–13].”
BackgroundA blast from the past: clearance of apoptotic cells regulates immune responses
Savill, J., Dransfield, I., Gregory, C., & Haslett, C. (2002) · Nature Reviews Immunology · doi:10.1038/nri957 · Cited by 1,574 · cited 1×
“Efficient removal of apoptotic cells and cellular debris by macrophages during acute injury or degenerative diseases is essential for repair of the damaged tissue, inflammation resolution, and disease recovery [11–13].”
BackgroundPerivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo
Hickey, W. F., & Kimura, H. (1988) · Science · doi:10.1126/science.3276004 · Cited by 1,466 · cited 1×
“Hematopoietic-derived myeloid cells physiologically migrate into the central nervous system (CNS) not only during development, but also in adulthood, and become resident perivascular macrophages and microglia [1–3].”
BackgroundTakahashi, K., Rochford, C. D. P., & Neumann, H. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041611 · Cited by 1,124 · cited 12×
“Recently, we discovered in vitro that the microglial triggering receptor expressed on myeloid cells-2 (TREM2) stimulates phagocytosis and down-regulates inflammatory signals in microglia via the signaling adaptor molecule DAP12 [14].”
BackgroundInfluentialSelf-citationYoussef, S., Stüve, O., Patarroyo, J. C., Ruiz, P. J., Radosevich, J. L., Hur, E. M., Bravo, M., Mitchell, D. J., Sobel, R. A., Steinman, L., et al. (2002) · Nature · doi:10.1038/nature01158 · Cited by 1,097 · cited 1×
“Most experimental approaches in EAE aim at skewing the cytokine profile of myelin-specific TH cells from TH1 to TH2 by altered peptide ligands [43,44], hydroxymethyl-glutaryl coenzyme A reductase inhibitors (‘‘statins’’) [45], or DNA vaccination combined with gene delivery of interleukin-4 (IL-4) [46].”
BackgroundInjection of adult neurospheres induces recovery in a chronic model of multiple sclerosis
Pluchino, S., Quattrini, A., Brambilla, E., Gritti, A., Salani, G., Dina, G., Galli, R., Del Carro, U., Amadio, S., Bergami, A., et al. (2003) · Nature · doi:10.1038/nature01552 · Cited by 1,068 · cited 1×
“Recently, brain-derived neurospheres have been injected intravenously and have been successfully used for cell therapy of EAE inducing repair and immunomodulatory activity [48,49], but these adult neural precursors are not a suitable cellular source for broad clinical applications.”
Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism
Pluchino, S., Zanotti, L., Rossi, B., Brambilla, E., Ottoboni, L., Salani, G., Martinello, M., Cattalini, A., Bergami, A., Furlan, R., et al. (2005) · Nature · doi:10.1038/nature03889 · Cited by 768
Experimental autoimmune encephalomyelitis repressed by microglial paralysis
Heppner, F. L., Greter, M., Marino, D., Falsig, J., Raivich, G., Hövelmeyer, N., Waisman, A., Rülicke, T., Prinz, M., Priller, J., et al. (2005) · Nature Medicine · doi:10.1038/nm1177 · Cited by 732 · cited 1×
“Furthermore, the microglial cytokine milieu determines the outcome of the inflammatory process in the animal model of MS, experimental autoimmune encephalomyelitis (EAE) [16–18].”
BackgroundSelf-citationTREMs in the immune system and beyond
Colonna, M. (2003) · Nature Reviews Immunology · doi:10.1038/nri1106 · Cited by 701 · cited 2×
“dendritic cells, and microglia [21].”
Research works printed but not linked: 49
- Hickey, 1988, Science, 239, 290
- Priller, 2001, Nat Med, 7, 1356
- Simard, 2004, FASEB J, 18, 998
- Flugel, 2001, J Neurosci Res, 66, 74
- Bechmann, 2005, FASEB J, 19, 647
- Malm, 2005, Neurobiol Dis, 18, 134
- Stalder, 2005, J Neurosci, 25, 11125
- Santambrogio, 2001, Proc Natl Acad Sci U S A, 98, 6295
- Servet-Delprat, 2002, BMC Immunol, 3, 15
- Asheuer, 2004, Proc Natl Acad Sci U S A, 101, 3557
- Voll, 1997, Nature, 390, 350
- Savill, 2002, Nat Rev Immunol, 2, 965
- Serhan, 2005, Nat Immunol, 6, 1191
- Takahashi, 2005, J Exp Med, 201, 647
- Prat, 2005, Curr Opin Neurol, 18, 225
- Carson, 2002, Glia, 40, 218
- Heppner, 2005, Nat Med, 11, 146
- Platten, 2005, Nat Med, 11, 252
- Willenbring, 2004, Nat Med, 10, 744
- Prinz, 2006, J Clin Invest, 116, 456
- Colonna, 2003, Nat Rev Immunol, 3, 445
- Matsuo, 1997, Am J Pathol, 150, 1253
- Paloneva, 2001, Neurology, 56, 1552
- Paloneva, 2003, J Exp Med, 198, 669
- Paloneva, 2002, Am J Hum Genet, 71, 656
- Schmid, 2002, J Neurochem, 83, 1309
- Cella, 2003, J Exp Med, 198, 645
- Turnbull, 2006, J Immunol, 177, 3520
- Bauer, 1994, J Neurosci Res, 38, 365
- Kotter, 2005, Neurobiol Dis, 18, 166
- Zhao, 2005, J Neurol Sci, 233, 87
- Schwab, 2004, Curr Opin Neurobiol, 14, 118
- Kerschensteiner, 2004, J Exp Med, 200, 1027
- Jander, 1998, Am J Pathol, 152, 975
- Bettelli, 1998, J Immunol, 161, 3299
- McGeachy, 2005, J Immunol, 175, 3025
- Cua, 2001, J Immunol, 166, 602
- Bakker, 2000, Immunity, 13, 345
- Steinman, 2001, Nat Immunol, 2, 762
- Zamvil, 2003, Neuron, 38, 685
- Arnold, 2005, J Neurol, 252, v25
- Lim, 2005, Mult Scler, 11, 532
- Evavold, 1993, Immunol Today, 14, 602
- Nicholson, 1995, Immunity, 3, 397
- Youssef, 2002, Nature, 420, 78
- Garren, 2001, Immunity, 15, 15
- Flugel, 2001, Eur J Immunol, 31, 11
- Pluchino, 2003, Nature, 422, 688
- Pluchino, 2005, Nature, 436, 266
Cited by
Items 101–200 of 414
Linnartz‐Gerlach, B., & Neumann, H. (2012) · Glia · doi:10.1002/glia.22359 · Cited by 136
“In another study, the expression of TREM2 increases the phagocytic capacity of mircoglia in vitro as well and even leads to the uptake of apoptotic cellular material without inflammation during experimental autoimmune encephalomyelitis (EAE), an animal model for multiple sclerosis (Takahashi et al., 2007).”
BackgroundSelf-citationCarson, M. J., Bilousova, T. V., Puntambekar, S. S., Melchior, B., Doose, J. M., & Ethell, I. M. (2007) · Neurotherapeutics · doi:10.1016/j.nurt.2007.07.002 · Cited by 135
“Both Takahashi et al.61 and Piccio et al.,62 however, demonstrated by blocking TREM2 or overexpressing TREM2 in EAE that this pathway promotes myeloid-mediated inhibition of T-cell responses (perhaps by antigen presentation–mediated generation of inhibitory T cells?).”
BackgroundMa, J., Jiang, T., Tan, L., & Yu, J.-T. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-8811-9 · Cited by 113
Guan, Y., Huang, G., Xu, M.-D., Gao, F., Lin, S., Huang, J., Wang, J., Li, Y., Wu, C.-H., Yao, S., et al. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.05.032 · Cited by 116
Ly6Chigh Monocytes Control Cerebral Toxoplasmosis
Biswas, A., Bruder, D., Wolf, S. A., Jeron, A., Mack, M., Heimesaat, M. M., & Dunay, I. R. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402037 · Cited by 120
Central nervous system myeloid cells as drug targets: current status and translational challenges
Biber, K. P. H., Möller, T., Boddeke, E., & Prinz, M. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.14 · Cited by 116
Self-citationZheng, H., Liu, C.-C., Atagi, Y., Chen, X.-F., Jia, L., Yang, L., He, W., Zhang, X., Kang, S. S., Rosenberry, T. L., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.03.004 · Cited by 110
Microglia and inflammation: conspiracy, controversy or control?
Fernandes, A., Miller-Fleming, L., & Pais, T. F. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1670-8 · Cited by 103
“Most attractively, it was demonstrated that when these cells were genetically modified to express NT-3, mice recovered from EAE, further supporting microglia as suitable therapeutic vehicles.”
BackgroundInfluentialTREM2 brain transcript-specific studies in AD and TREM2 mutation carriers
Del‐Aguila, J. L., Benítez, B. A., Li, Z., Dube, U., Mihindukulasuriya, K. A., Budde, J., Farias, F., Fernández, M. V., Ibáñez, L., Jiang, S., et al. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0319-3 · Cited by 116
“In the brain, it is primarily expressed by microglia and has been shown to control two signaling pathways: regulation of phagocytosis and suppression of inflammatory reactivity [3, 4].”
BackgroundProgressive multiple sclerosis
Bradl, M., & Lassmann, H. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0182-3 · Cited by 108
“Microglia cells can efficiently remove such debris, and they are uniquely equipped with a battery of receptors to perform this function: For example, with receptors recognizing the constant portion of immunoglobulins (FcγR), which require the prior opsonization of myelin by antimyelin antibodies [60]; with the complem…”
BackgroundAlzheimer’s Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid
Huynh, R. A., & Mohan, C. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00102 · Cited by 125
Lv, Q.-K., Tao, K., Wang, X.-B., Yao, X., Pang, M., Liu, J., Wang, F., & Liu, C. (2023) · Inflammation Research · doi:10.1007/s00011-022-01676-x · Cited by 125
“For example, microglia specifically expressing TREM2 can enhance the phagocytosis of microglia and attenuate inflammation by negatively regulating activation of NF-κB signal transduction mediated by TLR4 and transferring M1-like to M2-like phenotype polarization [170, 171].”
BackgroundIncreased Expression of TREM2 in Peripheral Blood of Alzheimer's Disease Patients
Hu, N., Tan, M., Yu, J., Sun, L., Tan, L., Wang, Y.-L., Jiang, T., & Tan, L. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130854 · Cited by 116
“Increased expression of TREM2 on microglia is coupled to enhanced phagocytosis and promotion of the alternative activation state of microglia, which is thought to be protective [23, 24].”
Animal Models of MS Reveal Multiple Roles of Microglia in Disease Pathogenesis
Gao, Z., & Tsirka, S. E. (2011) · Neurology Research International · doi:10.1155/2011/383087 · Cited by 112
“In this review, we discuss functions of microglia in MS, EAE and other experimental studies and review evidence implicating the critical roles of microglia in the complicated neural-immune networks.”
BackgroundThrash, J. C., Torbett, B. E., & Carson, M. J. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9657-1 · Cited by 110
Merson, T. D., Binder, M. D., & Kilpatrick, T. J. (2010) · NeuroMolecular Medicine · doi:10.1007/s12017-010-8112-z · Cited by 84
“…and induction of anti-inflammatory cytokine production which has been implicated in lessening the clinical severity of EAE, inflammatory infiltration, demy- elination and axonal damage, making it an attractive therapeutic target to promote repair (Piccio et al. 2007; Takahashi et al. 2007).”
BackgroundMicroglia in the developing brain: from immunity to behaviour
Schlegelmilch, T., Henke, K., & Peri, F. (2010) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2010.08.004 · Cited by 120
Öhrfelt, A., Axelsson, M., Malmeström, C., Novakova, L., Heslegrave, A., Blennow, K., Lycke, J., & Zetterberg, H. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458515624558 · Cited by 105
Soluble TREM2 and biomarkers of central and peripheral inflammation in neurodegenerative disease
Bekris, L. M., Khrestian, M., Dyne, E. D., Shao, Y. Y., Pillai, J. A., Rao, S. M., Bemiller, S. M., Lamb, B. T., Fernandez, H. H., & Leverenz, J. B. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.03.003 · Cited by 108
“TREM2 is involved in the activation of monocyte-derived dendritic cells, osteoclast development, enhancement of chemotaxis, and reduction of pro-inflammatory cytokine release while promoting antiinflammatory cytokine expression (Klesney-Tait et al., 2006; Neumann and Takahashi, 2007).”
BackgroundNegative regulation of glial engulfment activity by Draper terminates glial responses to axon injury
Logan, M. A., Hackett, R., Doherty, J., Sheehan, A. E., Speese, S. D., & Freeman, M. R. (2012) · Nature Neuroscience · doi:10.1038/nn.3066 · Cited by 106
Jiang, T., Yu, J., Zhu, X., Tan, M., Gu, L.-Z., Zhang, Y., & Tan, L. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.11.026 · Cited by 102
“…application of TREM2transduced bone marrowederived myeloid cell resulted in an upregulation of IL-10 in lesion areas of spinal cord, suggesting that modulation of anti-inflammatory cytokines may represent part of the mechanisms by which TREM2 attenuates neuroinflammation (Takahashi et al., 2007).”
BackgroundNF-κB Signaling and Inflammation—Drug Repurposing to Treat Inflammatory Disorders?
Roberti, A., Chaffey, L., & Greaves, D. R. (2022) · Biology · doi:10.3390/biology11030372 · Cited by 126
“This was accompanied by the amelioration of EAE symptoms and the reduction of demyelination and axon damage, while increased phagocytosis led to the clearance of destroyed myelin [164].”
BackgroundSaber, M., Kokiko‐Cochran, O. N., Puntambekar, S. S., Lathia, J. D., & Lamb, B. T. (2016) · Journal of Neurotrauma · doi:10.1089/neu.2016.4401 · Cited by 104
“42,73 Many in vivo studies have obtained differing results, however.”
Hosmane, S., Tegenge, M. A., Rajbhandari, L., Uapinyoying, P., Kumar, N. G., Thakor, N. V., & Venkatesan, A. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0203-12.2012 · Cited by 103
“Transplantation of myeloid cells transduced with TREM2 to enhance phagocytosis resulted in reduced injury and improved recovery from EAE (Fenoglio et al., 2007) (Takahashi et al., 2007).”
BackgroundThompson, K. K., & Tsirka, S. E. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030504 · Cited by 106
Iizasa, E., Chuma, Y., Uematsu, T., Kubota, M., Kawaguchi, H., Umemura, M., Toyonaga, K., Kiyohara, H., Yano, I., Colonna, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22620-3 · Cited by 92
Fueling neurodegeneration: metabolic insights into microglia functions
Sadeghdoust, M., Das, A., & Kaushik, D. K. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03296-0 · Cited by 114
“Also, TREM2 expression increased in microglia during EAE [130], and its inhibition during the effector phase of EAE was associated with widespread inflammation and demyelination in the brain [131].”
Vps35-dependent recycling of Trem2 regulates microglial function
Yin, J., Liu, X., He, Q., Zhou, L., Yuan, Z., & Zhao, S. (2016) · Traffic · doi:10.1111/tra.12451 · Cited by 90
Features of bilirubin-induced reactive microglia: From phagocytosis to inflammation
Silva, S. L., Vaz, A. R., Barateiro, A. P., Falcão, A. S., Fernandes, A. M. A., Brito, M. A., Silva, R. F. M., & Brites, D. M. T. O. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.08.010 · Cited by 98
Friend, Foe or Both? Immune Activity in Alzheimer’s Disease
Frost, G. R., Jonas, L. A., & Li, Y. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00337 · Cited by 98
“In the case of AD, targets such as Aβ or NFTs are recognized by TLRs resulting in a proinflammatory cytokine storm associated with release of TNF, IL-1 and NO, while recognition of cell debris or dystrophic neurites by microglial TREM2 receptors is associated with a phagocytic response along with an increase in TGFB a…”
BackgroundLinnartz, B., Wang, Y., & Neumann, H. (2010) · International Journal of Alzheimer's Disease · doi:10.4061/2010/587463 · Cited by 87
“Furthermore, TREM2 and SIRPβ1 are plaque-associated and increase the phagocytic activity of microglia [24, 25, 42, 43].”
Self-citationChen, Q., Zhang, K., Jin, Y., Zhu, T., Cheng, B., Shu, Q., & Fang, X. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201211-1967oc · Cited by 89
Liu, A., Chu, M., & Wang, Y. (2019) · Neuroscience Bulletin · doi:10.1007/s12264-018-0324-5 · Cited by 89
“improve the phagocytosis of apoptotic neurons [33].”
Can we switch microglia's phenotype to foster neuroprotection? Focus on multiple sclerosis
Giunti, D., Parodi, B., Cordano, C., Uccelli, A., & de Rosbo, N. K. (2013) · Immunology · doi:10.1111/imm.12177 · Cited by 101
Fluid biomarkers in multiple sclerosis: from current to future applications
Filippo, M. D., Gaetani, L., Centonze, D., Hegen, H., Kühle, J., Teunissen, C. E., Tintoré, M., Villar, L. M., Willemse, E. A. J., Zetterberg, H., et al. (2024) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2024.101009 · Cited by 111
“Despite the evidence of a role of TREM2 in animal models for demyelination and its elevation in foamy macrophages in MS lesions, 93 – 95 only few studies have investigated sTREM2 as biomarker for relevant contexts of use (diagnosis, prognosis, monitoring or treatment response) in MS. Increased CSF…”
BackgroundGaikwad, S. M., Larionov, S., Wang, Y., Dannenberg, H., Matozaki, T., Monsonego, A., Thal, D. R., & Neumann, H. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.090147 · Cited by 88
Self-citationTREM Receptors Connecting Bowel Inflammation to Neurodegenerative Disorders
Natale, G., Biagioni, F., Busceti, C. L., Gambardella, S., Limanaqi, F., & Fornai, F. (2019) · Cells · doi:10.3390/cells8101124 · Cited by 89
“This is reminiscent of what occurs in mice with experimental autoimmune encephalomyelitis (EAE), where TREM-2 is highly expressed on microglial cells and macrophages, while its blockade exacerbates the inflammatory process [78,79].”
ResultFarah, M. H., Pan, B., Hoffman, P. N., Ferraris, D. V., Tsukamoto, T., Nguyen, T., Wong, P. C., Price, D. L., Slusher, B. S., & Griffin, J. W. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.6810-10.2011 · Cited by 93
Models of multiple sclerosis: new insights into pathophysiology and repair
Lassmann, H. (2008) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3282fee94a · Cited by 81
Morris, G., Puri, B. K., & Frye, R. E. (2017) · Metabolic Brain Disease · doi:10.1007/s11011-017-0077-2 · Cited by 85
“array of downstream kinases cumulating in cellular activation (Poliani et al. 2015; Takahashi et al. 2007).”
BackgroundGalectin-3-Mediated Glial Crosstalk Drives Oligodendrocyte Differentiation and (Re)myelination
Thomas, L., & Pasquini, L. A. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00297 · Cited by 76
Kurisu, K., Zheng, Z., Kim, J. Y., Shi, J., Kanoke, A., Liu, J., Hsieh, C. L., & Yenari, M. A. (2018) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x18817282 · Cited by 80
“Interestingly, others have shown that TREM2 deficiency leads to a potentiation of the immune responses in related disease models.(11,43) TREM2 overexpression has similarly been shown to inhibit the production of pro-inflammatory cytokines, but increasing the production of the anti-inflammatory cytokine IL-10.”
BackgroundGalectin-3 controls the response of microglial cells to limit cuprizone-induced demyelination
Hoyos, H. C., Rinaldi, M., Méndez‐Huergo, S. P., Marder, M., Rabinovich, G. A., Pasquini, J. M., & Pasquini, L. A. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.10.023 · Cited by 83
Coelho, I., Duarte, N., Barros, A., Macedo, M. P., & Penha-Gonçalves, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.616044 · Cited by 70
Martiskainen, H., Viswanathan, J., Nykänen, N.-P., Kurki, M., Helisalmi, S., Natunen, T., Sarajärvi, T., Kurkinen, K. M. A., Pursiheimo, J.-P., Rauramaa, T., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.09.003 · Cited by 70
“TREM2 is a microglial protein, which has an important function in clearing debris from the brain (Takahashi et al., 2007).”
BackgroundThe innate immune system in Alzheimer's disease
Boutajangout, A., & Wisniewski, T. (2013) · International Journal of Cell Biology · doi:10.1155/2013/576383 · Cited by 69
“In various models of multiple sclerosis increased microglial expression of TREM2 is associated with increased phagocytosis and a promotion of aM2-like activation state of microglia, which is thought to have protective effects [28, 29].”
BackgroundTREM2 alters the phagocytic, apoptotic and inflammatory response to Aβ42 in HMC3 cells
Akhter, R., Shao, Y., Formica, S., Khrestian, M., & Bekris, L. M. (2021) · Molecular Immunology · doi:10.1016/j.molimm.2020.12.035 · Cited by 68
Yu, J.-T., Jiang, T., Wang, Y.-L., Wang, H.-F., Zhang, W., Hu, N., Tan, L., Sun, L., Tan, M.-S., Zhu, X.-C., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.10.075 · Cited by 68
Development of the microglial phenotype in culture
Szabó, M., & Gulya, K. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.03.033 · Cited by 72
IFN-γ ameliorates autoimmune encephalomyelitis by limiting myelin lipid peroxidation
Sosa, R. A., Murphey, C. L., Robinson, R. R., & Forsthuber, T. G. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505955112 · Cited by 74
“Loss of TREM2 function impairs microglial phagocytosis (51, 52), and enhanced TREM2dependent phagocytosis of degenerated myelin can ameliorate EAE (51).”
BackgroundEllrichmann, G., Thöne, J., Lee, D.-H., Rupec, R., Gold, R., & Linker, R. A. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-15 · Cited by 76
Lee, M. J., Bing, S. J., Choi, J., Jang, M., Lee, G., Lee, H., Chang, B. S., Jee, Y., Lee, S. J., & Cho, I. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0116-1 · Cited by 70
“In a study, over-expression of the triggering receptor expressed on myeloid cells 2 (TREM2), a NF-κB target gene, in myeloid cells ameliorated clinical symptoms and reduced demyelination as well as axonal damage in the spinal cord of EAE mice, suggesting a neuroprotective role of myeloid NF-κB signaling [56].”
BackgroundTREM2 Ameliorates Neuronal Tau Pathology Through Suppression of Microglial Inflammatory Response
Jiang, T., Zhang, Y., Gao, Q., Ou, Z., Gong, P., Shi, J., Wu, L., & Zhou, J. (2018) · Inflammation · doi:10.1007/s10753-018-0735-5 · Cited by 66
Microglia recapitulate a hematopoietic master regulator network in the aging human frontal cortex
Wehrspaun, C. C., Haerty, W., & Ponting, C. P. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.04.008 · Cited by 64
Differential roles of resident microglia and infiltrating monocytes in murine CNS autoimmunity
Shemer, A., & Jung, S. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0519-z · Cited by 71
Targeting Microglia-Synapse Interactions in Alzheimer’s Disease
Piccioni, G., Mango, D., Saidi, A., Corbo, M., & Nisticò, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052342 · Cited by 69
Lue, L.-F., Schmitz, C., & Walker, D. G. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2014.09.050 · Cited by 63
“Expression of TREM2 and DAP12 has been investigated in the mouse and the human brain (Schmid et al., 2002; Kiialainen et al., 2005; Takahashi et al., 2007; Roumier et al., 2008; Wakselman et al., 2008; Thrash et al., 2009; Forabosco et al., 2013).”
Pifarré, P., Gutièrrez‐Mecinas, M., Prado, J., Usero, L., Roura‐Mir, C., Giralt, M., Hidalgo, J., & García, A. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.10.021 · Cited by 66
“, 2006), while debris clearance by myeloid cells promotes repair in EAE (Takahashi et al., 2007).”
Glial smog: Interplay between air pollution and astrocyte-microglia interactions
Gómez‐Budia, M., Konttinen, H., Saveleva, L., Korhonen, P., Jalava, P., Kanninen, K. M., & Malm, T. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104715 · Cited by 62
Tong, H.-I., Kang, W., Davy, P. M. C., Shi, Y., Sun, S., Allsopp, R., & Lu, Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154022 · Cited by 63
“GAPDH NM_008084 forward: 5’–CTCCACTCACGGCAAATTCAA–3’ reverse: 5’–GATGACAAGCTTCCCATTCTCG–3’ [7]”
InfluentialPetković, F., Campbell, I. L., Gonzalez, B., & Castellano, B. (2016) · Glia · doi:10.1002/glia.23043 · Cited by 59
“TREM2 was shown to be essential for microglial activation and efficient removal of myelin debris in the cuprizone (Cantoni et al., 2015; Poliani et al., 2015), as well as in the EAE model (Takahashi et al., 2007).”
BackgroundThe Role of Microglia in Prion Diseases: A Paradigm of Functional Diversity
Obst, J., Simon, E., Mancuso, R., & Gómez‐Nicola, D. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00207 · Cited by 63
“TREM2 is an innate immune cell receptor expressed on microglia and other myeloid cells is thought to be involved in phagocytosis of apoptotic neurons and promoting an anti-inflammatory phenotype (Takahashi et al., 2005, 2007; Hsieh et al., 2009).”
BackgroundMicroglial Responses to Brain Injury and Disease: Functional Diversity and New Opportunities
Lyu, J., Jiang, X., Leak, R. K., Shi, Y., Hu, X., & Chen, J. (2020) · Translational Stroke Research · doi:10.1007/s12975-020-00857-2 · Cited by 67
The triggering receptor expressed on myeloid cells (TREM) in inflammatory bowel disease pathogenesis
Genua, M., Rutella, S., Correale, C., & Danese, S. (2014) · Journal of Translational Medicine · doi:10.1186/s12967-014-0293-z · Cited by 68
“TREM-2 expression is up-regulated on microglia cells and infiltrating macrophages in both the spinal cord and brain during inflammatory burst [12], and myeloid cells transduced with TREM-2 dampen EAE in mice, by migrating to the CNS and releasing antiinflammatory cytokines [50].”
BackgroundAge and Sex Influence the Neuro-inflammatory Response to a Peripheral Acute LPS Challenge
Murtaj, V., Belloli, S., Di Grigoli, G., Pannese, M., Ballarini, E., Rodriguez-Menendez, V., Marmiroli, P., Cappelli, A., Masiello, V., Monterisi, C., et al. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00299 · Cited by 58
Gervois, P., & Lambrichts, I. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01668 · Cited by 62
Hao, W., Liu, Y., Liu, S., Walter, S., Grimm, M. O. W., Kiliaan, A. J., Penke, B., Hartmann, T., Rübe, C. E., Menger, M. D., et al. (2010) · Brain · doi:10.1093/brain/awq325 · Cited by 61
Ruganzu, J. B., Peng, X., He, Y., Wu, X., Zheng, Q., Ding, B., Lin, C., Guo, H., Yang, Z., Zhang, X. L., et al. (2021) · Molecular Immunology · doi:10.1016/j.molimm.2021.12.018 · Cited by 57
Wang, P., Yang, P., Qian, K., Li, Y., Xu, S., Meng, R., Guo, Q., Cheng, Y., Cao, J., Xu, M., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121360 · Cited by 58
Porrini, V., Lanzillotta, A., Branca, C., Benarese, M., Parrella, E., Lorenzini, L., Calzà, L., Flaibani, R., Spano, P., Imbimbo, B. P., et al. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.10.029 · Cited by 60
Immune response by microglia in the spinal cord
Olson, J. K. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05536.x · Cited by 60
Fischer, H. J., Finck, T. L. K., Pellkofer, H., Reichardt, H. M., & Lühder, F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01200 · Cited by 57
TREM2 Promotes Immune Evasion by Mycobacterium tuberculosis in Human Macrophages
Dabla, A., Liang, Y. C., Rajabalee, N., Irwin, C. L., Moonen, C. G. J., Willis, J. V., Berton, S., & Sun, J. (2022) · mBio · doi:10.1128/mbio.01456-22 · Cited by 61
Carbajosa, G., Malki, K., Lawless, N., Wang, H., Ryder, J. W., Wozniak, E., Wood, K., Mein, C. A., Dobson, R., Collier, D. A., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.04.019 · Cited by 56
Rohn, T. T. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/860959 · Cited by 63
“In the second study, intravenous application of TREM2-transduced myeloid cells limited tissue destruction and facilitated repair in a murine model of MS [68].”
BackgroundYao, Y., Li, H., Chen, J., Xu, W., Yang, G., Bao, Z., Xia, D., Lu, G., Hu, S., & Zhou, J. (2016) · Oncotarget · doi:10.18632/oncotarget.8813 · Cited by 57
“TREM-2 functioned to inhibit TNF-α and IL-6 production by MΦs in response to TLR ligands [10], whereas overexpression in myeloid cells led to less TNF and inducible nitric oxide [19], but more IL-10 [19, 20].”
Deming, Y. K., Li, Z., Benítez, B. A., & Cruchaga, C. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1486823 · Cited by 56
“expressing WT Trem2 into the EAE mouse model for MS, suggest that cell-based therapeutics may be a viable option [95].”
BackgroundResultInfluentialInterferon β-Mediated Protective Functions of Microglia in Central Nervous System Autoimmunity
Scheu, S., Ali, S., Mann‐Nüttel, R., Richter, L., Arolt, V., Dannlowski, U., Kuhlmann, T., Klotz, L., & Alferink, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20010190 · Cited by 53
“Further, overexpression of the phagocytosis triggering receptor TREM2 reduced the severity of clinical symptoms in EAE [205].”
BackgroundEAAT expression by macrophages and microglia: still more questions than answers
Gras, G. S., Samah, B., Hubert, A., Léone, C., Porcheray, F., & Rimaniol, A. (2011) · Amino Acids · doi:10.1007/s00726-011-0866-6 · Cited by 49
“The receptors needed for recognition and phagocytosis of apoptotic bodies are thus expressed by parenchymal microglia, including TREM2, a critical mediator of this anti-inflammatory programme ( Takahashi et al. 2007 ).”
BackgroundVirgili, N., Espinosa‐Parrilla, J. F., Mancera, P., Pastén-Zamorano, A., Gimeno‐Bayón, J., Rodríguez, M. J., Mahy, N., & Pugliese, M. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-149 · Cited by 52
Desestret, V., Riou, A., Chauveau, F., Cho, T., Devillard, E., Marinescu, M., Ferrera, R., Rey, C., Chanal, M., Angoulvant, D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067063 · Cited by 48
Sweepers in the CNS: Microglial Migration and Phagocytosis in the Alzheimer Disease Pathogenesis
Noda, M., & Suzumura, A. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/891087 · Cited by 57
“Their expression correlates with clearance of apoptotic neurons by microglia without inflammation [90–92].”
BackgroundDifferential Modulation of TREM2 Protein during Postnatal Brain Development in Mice
Chertoff, M., Shrivastava, K., González, B., Acarín, L., & Giménez‐Llort, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072083 · Cited by 54
Modeling CNS microglia: the quest to identify predictive models
Carson, M. J., Crane, J., & Xie, A. X. (2008) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2008.07.006 · Cited by 56
“The highest levels and percentage of Trem2 expressing microglia are found in the cingulate cortex, corpus collosum, fimbiria and entorhinal cortex, whereas the lowest are found in the circumventricular organs and the laterodorsal thalamic nucleus.”
BackgroundMethodInfluentialThe Role of TREM2 in Alzheimer’s Disease and Other Neurological Disorders
Yaghmoor, F., Noorsaeed, A., Alsaggaf, S., Aljohani, W., Scholtzova, H., Boutajangout, A., & Wısnıewskı, T. (2014) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000160 · Cited by 52
“In several models of multiple sclerosis increased microglial expression of TREM2 has been shown to enhance phagocytosis and promotes a M2-like activation state of microglia, which is thought to have protective effects [46–48].”
BackgroundTREM2 expression and amyloid‐beta phagocytosis in Alzheimer's disease
La Rosa, F., Agostini, S., Piancone, F., Marventano, I., Hernis, A., Fenoglio, C., Galimberti, D., Scarpini, E., Saresella, M., & Clerici, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108626 · Cited by 50
“Thus, in vitro results showed that an anti-inflammatory milieu results in an upregulation of TREM2 expression [85], while pro-inflammatory proteins, such as TNFα, IL1β or lipopolysaccharide (LPS) decrease TREM2 expression [86–88].”
BackgroundBordeleau, M., de Cossío, L. F., Lacabanne, C., Savage, J. C., Vernoux, N., Chakravarty, M., & Tremblay, M. (2021) · Brain, Behavior, & Immunity - Health · doi:10.1016/j.bbih.2021.100281 · Cited by 42
Singh, A. K., Mishra, G., Maurya, A., Awasthi, R., Kumari, K., Thakur, A., Rai, A., Rai, G. K., Sharma, B., Kulkarni, G. T., et al. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190903102822 · Cited by 47
Melero‐Jerez, C., Alonso-Gómez, A., Moñivas, E., Lebrón‐Galán, R., Machín-Díaz, I., de Castro, F., & Clemente, D. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104869 · Cited by 46
Jeong, H., Ji, K., Kim, J., Jou, I., & Joe, E.-H. (2013) · Molecular Brain · doi:10.1186/1756-6606-6-28 · Cited by 50
CX3CL1 protects neurons against excitotoxicity enhancing GLT-1 activity on astrocytes
Catalano, M., Lauro, C., Cipriani, R., Chece, G., Ponzetta, A., Angelantonio, S. D., Ragozzino, D., & Limatola, C. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.07.020 · Cited by 48
“, 2006), TREM2 (Takahashi et al., 2007) and CD200R (Hoek et al.”
Glebov, K., Wunderlich, P., Karaca, I., & Walter, J. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0479-9 · Cited by 47
“On the other hand, activation of TREM2 in microglia increased the expression of chemokine receptors and cell migration [21, 22].”
The immunobiology of Campylobacter jejuni: Innate immunity and autoimmune diseases
Phongsisay, V. (2015) · Immunobiology · doi:10.1016/j.imbio.2015.12.005 · Cited by 47
Subramanian, S., Pallati, P. K., Rai, V., Sharma, P., Agrawal, D. K., & Nandipati, K. C. (2017) · Obesity · doi:10.1002/oby.21714 · Cited by 47
“expression and activity of TREM-2 are anti-inflammatory (11,12).”
Dean, H. B., Roberson, E. D., & Song, Y. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01252 · Cited by 45
Morris, G., Puri, B. K., Maes, M. H. J., OLIVE, L. S., Berk, M., & Carvalho, A. F. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.109858 · Cited by 43
Microglia: The Missing Link to Decipher and Therapeutically Control MS Progression?
Geladaris, A., Häusler, D., & Weber, M. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073461 · Cited by 47
Alzheimer’s disease: rare variants with large effect sizes
Del-Aguila, J. L., Koboldt, D. C., Black, K., Chasse, R., Norton, J., Wilson, R. K., & Cruchaga, C. (2015) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2015.07.008 · Cited by 41
“In the brain, TREM2 is primarily expressed on microglia and has been shown to control two signaling pathways: regulation of phagocytosis and suppression of inflammatory reactivity [24,25].”
Kim, H., Walczak, P., Kerr, C. L., Galpoththawela, C., Gilad, A. A., Muja, N., & Bulte, J. W. M. (2012) · Stem Cells · doi:10.1002/stem.1218 · Cited by 45
Xu, H., Mu, S., & Qin, W. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.08.130 · Cited by 44
Metadata
- Authors
- Takahashi, K., Prinz, M., Stagi, M., Chechneva, O., & Neumann, H.
- Affiliations
- University of Bonn (DE)
- Universitätsmedizin Göttingen (DE)
- Corresponding author
- Neumann, Harald
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2007-04-10
- Volume
- 4
- Issue
- 4
- Pages
- e124
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC1851623
- OpenAlex
- W2116226263
- Cited by
- 414
- References
- 51
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 28 · 2023: 18 · 2022: 19 · 2021: 22 · 2020: 19 · 2019: 23 · 2018: 23 · 2017: 28 · 2016: 24 · 2015: 35 · 2014: 32 · 2013: 34 · 2012: 16
- FWCI
- 13.49
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen) (submittedVersion, cc-by)
- Funders
- Deutsche Forschungsgemeinschaft (SFB 704)
- Gemeinnützige Hertie-Stiftung
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- TREM2, multiple sclerosis, experimental autoimmune encephalomyelitis, myeloid precursors, microglia, phagocytosis, myelin debris clearance, demyelination, axonal injury, neuroinflammation, neurorepair, gene therapy, bone marrow-derived cells, anti-inflammatory cytokines
- MeSH terms
- Animals, Cell Differentiation, Cell Movement, Cells, Cultured, Disease Models, Animal, Encephalomyelitis, Autoimmune, Experimental, Female, Flow Cytometry, Gene Expression Regulation, Genes, Synthetic, Genetic Vectors, Humans, Membrane Glycoproteins, Mice, Inbred C57BL, Monocytes, Multiple Sclerosis, Neurons, Phagocytosis, Promoter Regions, Genetic, Receptors, Immunologic, Transduction, Genetic, Genetic Therapy, Lentivirus, Granulocyte-Macrophage Colony-Stimulating Factor, Cytokines, Interleukin-10, Apoptosis, Microglia, Genes, Reporter, Hematopoietic Stem Cell Transplantation, Cell Lineage, Myeloid Cells, Mice, Nitric Oxide Synthase Type II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.